Ornidazole
Also known as: Ornidazole is a derivative of 5-nitroimidazole
Ornidazole is a nitroimidazole antiprotozoal agent used in ameba and trichomonas infections. It is partially plasma-bound and also has radiation-sensitizing action.
Primary Characteristics
Ornidazole is also known as Ornidazole is a derivative of 5-nitroimidazole.
It belongs to Nitroimidazole.
Molecular Weight: 219.6 · Non-proprietary name: Ornidazole.

Pharmacokinetics
Distribution: Ornidazole has a plasma protein binding is <15%.
Elimination: it is metabolised via Hepatic, plasma half-life is 12-14 hrs.
Advertisement
Indications
Ornidazole is primarily indicated in conditions like Amebiasis, Amoebic dysentry, Bacterial vaginosis, Giardiasis, Trichomoniasis.
Contraindications
Ornidazole is contraindicated in conditions like Hypersensitivity to the drug.
Dosage
Ornidazole's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 1 g | 1 g | — | I/V Infusion | 30 min before surgery |
| 1.5 gm | 1.5 gm | — | PO | For the treatment of Amoebic dysentery once daily for 3 days. |
| 1.5 gm | 1.5 gm | — | PO | For the treatment of Giardiasis once daily for 1-2 days. |
| 500 mg | 500 mg | — | PO | For the treatment of Trichomoniasis twice a day for 5 days. |
| 500 mg | 500 mg | — | PO | For the treatment of Amoebiasis twice a day for 5-10 days. |
| Paediatric Dosage (20kg) | ||||
| 10 mg/kg | 10 mg/kg | Every 12h | I/V | For 5 to 10 days |
| 25 mg/kg | 25 mg/kg | — | Oral | As a single dose |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
The signs and symptoms that are produced after acute overdosage of Ornidazole are Nausea, fatigue, Headache, Rashes , Vertigo , Insomnia, Pyrosis.
Ornidazole is known to cause more or less tolerable side effects which are usually transient. These include Ataxia, dizziness, Headache, Nausea, Skin rashes, Urticaria, Weakness.
Warnings / Precautions
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.6.4.1 — Antiamebic & antigiardiasis drugs